跳至主要内容
临床试验/NCT02817906
NCT02817906终止3 期

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 in the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

Intra-Cellular Therapies, Inc.0 个研究点目标入组 177 人开始时间: 2016年8月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
177
主要终点
Change From Baseline in the Cohen-Mansfield Agitation Inventory - Community Version (CMAI-C)

研究概览

简要总结

This is a randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ITI-007 versus placebo administered orally once daily in the treatment of agitation in patients with dementia, including Alzheimer's disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of probable Alzheimer's disease
  • Clinically significant symptoms of agitation secondary to probable Alzheimer's disease
  • Able to attend outpatient clinic visits with primary caregiver

排除标准

  • Unable to comply with study procedures
  • Considered medically inappropriate for study participation

研究组 & 干预措施

ITI-007

Experimental

9 mg ITI-007 administered as a solid oral dose formulation once daily for 4 weeks.

干预措施: ITI-007 (Drug)

Placebo

Placebo Comparator

Placebo administered as a visually-matched solid oral dose formulation once daily for 4 weeks

干预措施: Placebo (Drug)

结局指标

主要结局

Change From Baseline in the Cohen-Mansfield Agitation Inventory - Community Version (CMAI-C)

时间窗: 4 weeks (28 Days)

The Cohen-Mansfield Agitation Inventory-Community Version is a 37-item scale for identifying and quantifying agitated behaviors in elderly persons in a community setting. Each item is rated from 1='Never' to 7='Several Times Per Hour'. Each category contains a pre-specified subset of the CMAI-C items. The score of each category is the sum of the CMAI-C items included in that category: Aggressive Behavior-Sum of 9 CMAI-C items, ranges from 9 to 63; Non-Aggressive Agitated Behavior-Sum of 6 CMAI-C items, ranges from 6 to 42; Verbally Agitated Behavior-Sum of 4 CMAI-C items, ranges from 4 to 28.

次要结局

  • Change From Baseline in the Clinical Global Impression Scale for Severity of Illness (CGI-S)(4 weeks (28 Days))

研究者

申办方类型
Industry
责任方
Sponsor

相似试验